Coexisting patterns and significance of serum HBV RNA and HBV DNA in patients with treatment-naïve chronic hepatitis B virus infection

AimThe study aimed to explore the coexisting patterns and assess the significance of serum hepatitis B virus (HBV) RNA and traditional virological biomarkers in patients with antiviral treatment-naïve chronic hepatitis B virus (HBV) infection.MethodsSerum HBV RNA, HBV DNA, hepatitis B surface antige...

Full description

Saved in:
Bibliographic Details
Main Authors: Kun-yan Hao, Ye Fan, Yi-qing Zhang, Yue-cheng Yu
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2024.1525476/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841555195511701504
author Kun-yan Hao
Kun-yan Hao
Ye Fan
Yi-qing Zhang
Yue-cheng Yu
author_facet Kun-yan Hao
Kun-yan Hao
Ye Fan
Yi-qing Zhang
Yue-cheng Yu
author_sort Kun-yan Hao
collection DOAJ
description AimThe study aimed to explore the coexisting patterns and assess the significance of serum hepatitis B virus (HBV) RNA and traditional virological biomarkers in patients with antiviral treatment-naïve chronic hepatitis B virus (HBV) infection.MethodsSerum HBV RNA, HBV DNA, hepatitis B surface antigen (HBsAg), and hepatitis B envelope antigen (HBeAg) levels were measured and compared in patients with chronic hepatitis B virus infection. The HBV RNA levels were determined using a simultaneous amplification and testing assay.ResultsIn the HBeAg-negative (HBeAg [−]) patients, the serum HBV RNA detectable (HBV RNA [+]) rate (33.33%, 14/42) was significantly lower than the serum HBV DNA detectable (HBV DNA [+]) rate (95.24%, 40/42; p < 0.001). However, there was no significant difference in the HBeAg-positive (HBeAg [+]) patients (p > 0.05). The HBV RNA (+) rate (33.33%, 14/42) was lower in the HBeAg-negative patients than in the HBeAg-positive patients (100%, 17/17, p < 0.001), while the HBV DNA (+) rate (95.24%, 40/42 vs. 94.12%, 16/17) showed no significant difference (p > 0.05). The HBV RNA (+) rates showed a significant difference (p < 0.001) among the different HBsAg levels (10.00, 65.00, 84.21%, p < 0.001), while the HBV DNA (+) rate showed no significant difference (p > 0.05). In all patients, serum HBV RNA correlated well with HBV DNA (r = 0.72, p < 0.001), HBeAg (r = 0.68, p < 0.001), and HBsAg (r = 0.66, p < 0.001). However, the correlations between HBV RNA and other biomarkers varied across the different HBsAg and HBeAg levels.ConclusionThe coexisting patterns of serum HBV RNA and HBV DNA varied with the levels of HBeAg and HBsAg in the patients with treatment-naïve chronic HBV infection. This further suggests that serum HBV RNA should be included in the key index panel to accurately evaluate the natural history of HBV infection and the effects of antiviral treatment.
format Article
id doaj-art-d33cda7f16c54954a62df1f03f4ea99c
institution Kabale University
issn 2296-858X
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Medicine
spelling doaj-art-d33cda7f16c54954a62df1f03f4ea99c2025-01-08T06:11:37ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2025-01-011110.3389/fmed.2024.15254761525476Coexisting patterns and significance of serum HBV RNA and HBV DNA in patients with treatment-naïve chronic hepatitis B virus infectionKun-yan Hao0Kun-yan Hao1Ye Fan2Yi-qing Zhang3Yue-cheng Yu4Center of Hepatology and Department of Infectious Disease, Jinling Hospital Affiliated to School of Medicine, Nanjing University, Nanjing, ChinaState Key Laboratory of Organ Failure Research, Guangdong Province key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, ChinaCenter of Hepatology and Department of Infectious Disease, Jinling Hospital Affiliated to School of Medicine, Nanjing University, Nanjing, ChinaDepartment of Clinical Laboratory, Jinling Hospital Affiliated to School of Medicine, Nanjing University, Nanjing, ChinaCenter of Hepatology and Department of Infectious Disease, Jinling Hospital Affiliated to School of Medicine, Nanjing University, Nanjing, ChinaAimThe study aimed to explore the coexisting patterns and assess the significance of serum hepatitis B virus (HBV) RNA and traditional virological biomarkers in patients with antiviral treatment-naïve chronic hepatitis B virus (HBV) infection.MethodsSerum HBV RNA, HBV DNA, hepatitis B surface antigen (HBsAg), and hepatitis B envelope antigen (HBeAg) levels were measured and compared in patients with chronic hepatitis B virus infection. The HBV RNA levels were determined using a simultaneous amplification and testing assay.ResultsIn the HBeAg-negative (HBeAg [−]) patients, the serum HBV RNA detectable (HBV RNA [+]) rate (33.33%, 14/42) was significantly lower than the serum HBV DNA detectable (HBV DNA [+]) rate (95.24%, 40/42; p < 0.001). However, there was no significant difference in the HBeAg-positive (HBeAg [+]) patients (p > 0.05). The HBV RNA (+) rate (33.33%, 14/42) was lower in the HBeAg-negative patients than in the HBeAg-positive patients (100%, 17/17, p < 0.001), while the HBV DNA (+) rate (95.24%, 40/42 vs. 94.12%, 16/17) showed no significant difference (p > 0.05). The HBV RNA (+) rates showed a significant difference (p < 0.001) among the different HBsAg levels (10.00, 65.00, 84.21%, p < 0.001), while the HBV DNA (+) rate showed no significant difference (p > 0.05). In all patients, serum HBV RNA correlated well with HBV DNA (r = 0.72, p < 0.001), HBeAg (r = 0.68, p < 0.001), and HBsAg (r = 0.66, p < 0.001). However, the correlations between HBV RNA and other biomarkers varied across the different HBsAg and HBeAg levels.ConclusionThe coexisting patterns of serum HBV RNA and HBV DNA varied with the levels of HBeAg and HBsAg in the patients with treatment-naïve chronic HBV infection. This further suggests that serum HBV RNA should be included in the key index panel to accurately evaluate the natural history of HBV infection and the effects of antiviral treatment.https://www.frontiersin.org/articles/10.3389/fmed.2024.1525476/fullHBV RNAHBV DNAHBsAgHBeAgcoexisting patternstreatment-naïve HBV-infectors
spellingShingle Kun-yan Hao
Kun-yan Hao
Ye Fan
Yi-qing Zhang
Yue-cheng Yu
Coexisting patterns and significance of serum HBV RNA and HBV DNA in patients with treatment-naïve chronic hepatitis B virus infection
Frontiers in Medicine
HBV RNA
HBV DNA
HBsAg
HBeAg
coexisting patterns
treatment-naïve HBV-infectors
title Coexisting patterns and significance of serum HBV RNA and HBV DNA in patients with treatment-naïve chronic hepatitis B virus infection
title_full Coexisting patterns and significance of serum HBV RNA and HBV DNA in patients with treatment-naïve chronic hepatitis B virus infection
title_fullStr Coexisting patterns and significance of serum HBV RNA and HBV DNA in patients with treatment-naïve chronic hepatitis B virus infection
title_full_unstemmed Coexisting patterns and significance of serum HBV RNA and HBV DNA in patients with treatment-naïve chronic hepatitis B virus infection
title_short Coexisting patterns and significance of serum HBV RNA and HBV DNA in patients with treatment-naïve chronic hepatitis B virus infection
title_sort coexisting patterns and significance of serum hbv rna and hbv dna in patients with treatment naive chronic hepatitis b virus infection
topic HBV RNA
HBV DNA
HBsAg
HBeAg
coexisting patterns
treatment-naïve HBV-infectors
url https://www.frontiersin.org/articles/10.3389/fmed.2024.1525476/full
work_keys_str_mv AT kunyanhao coexistingpatternsandsignificanceofserumhbvrnaandhbvdnainpatientswithtreatmentnaivechronichepatitisbvirusinfection
AT kunyanhao coexistingpatternsandsignificanceofserumhbvrnaandhbvdnainpatientswithtreatmentnaivechronichepatitisbvirusinfection
AT yefan coexistingpatternsandsignificanceofserumhbvrnaandhbvdnainpatientswithtreatmentnaivechronichepatitisbvirusinfection
AT yiqingzhang coexistingpatternsandsignificanceofserumhbvrnaandhbvdnainpatientswithtreatmentnaivechronichepatitisbvirusinfection
AT yuechengyu coexistingpatternsandsignificanceofserumhbvrnaandhbvdnainpatientswithtreatmentnaivechronichepatitisbvirusinfection